The company offers specialist microbiology testing and a consultant-led infection prevention and control service, working with private and NHS healthcare facilities throughout the UK.
The company’s activities are bolstered by coveted relationships with trusted consultants, which have underpinned the business’s scalability to support clients in meeting their patients’ needs.
Our clients are offering the company for sale to facilitate lifestyle changes. Offers invited.
Key Highlights
- Retains long-standing, lucrative relationships with a vast network of healthcare facilities, including well-known healthcare providers.
- Wealth of in-house and external expertise in place.
- A fully relocatable opportunity.
- Grown considerably since its inception; an ideal acquisition opportunity.
- Current pressures and projected growth within the hospital sector could create increased demand for the company’s services.
Financial Highlights
- Generated a YE24 turnover of £550k, with an EBITDA of £154k.
Average adjusted EBITDA margin of 44% between YE21 and YE24.
- Secures repeat business from all clients, owing to ongoing requirements to support patient needs.
NB: The dip in turnover in YE24 was due to a shift from site visits to virtual meetings; however, this is expected to increase the company’s profits due to decreased travel and expenses.
